| Company Name: | FEI Company | | Ticker Symbol: | FEIC | | | WWW Address: | www.feic.com | | CEO: | Dr. Don R. Kania, Ph.D. | | No. of Employees: | 1,803 | | Common Issue Type: | CS | | Business Description: | The Company is a supplier of instruments for nanoscale imaging, analysis and prototyping to enable research, development and manufacturing in a range of industrial, academic and research institutional applications.
|
| | | Industry Information: | ELECTRONICS - Scientific & Technical Instruments [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 24.8 |  -0.05 | 24.11 | 25.53 | 24.88 | 24.99 | 24.78 | 184714 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 935.0 | 37.7 | 1.18 | 0.61 | 0.00 | 41.3 | 0.0 | 26.50 - 11.36 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 24.80 | $ | | PE Ratio - LTM | 41.3 | |
| Market Capitalisation | 934.6 | mil |
| Latest Shares Outstanding | 37.7 | mil |
| Earnings pS (EPS) | 0.61 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 332,323 | $ |
| Effective Tax Rate | 26.2 | % |
| Float | 37.4 | mil |
| Float as % of Shares Outstanding | 99.6 | % |
| Foreign Sales | 395 | mil |
| Domestic Sales | 205 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 11.70 | % |
| Gross Profit Margin | 43.4 | % |
| EBITDA Margin | 9.9 | % |
| Pre-Tax Profit Margin | 5.2 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 2.5 | % |
| Return on Equity (ROE) | 4.2 | % |
| Return on Capital Invested (ROCI) | 3.5 | % |
| Current Ratio | 2.9 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 6.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.30 | |
| LT Debt/Total Capital | 15.0 | % |
| Working Capital pS | 12.59 | $ |
| Cash pS | 3.91 | $ |
| Book-Value pS | 14.97 | $ |
| Tangible Book-Value pS | 13.78 | $ |
| Cash Flow pS | 1.15 | $ |
| Free Cash Flow pS | 1.18 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.66 | |
| Price/Tangible Book Ratio | 1.80 | |
| Price/Cash Flow | 21.6 | |
| Price/Free Cash Flow | 20.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 31.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 98 | 2,249 | 6,906 |
| 4 Weeks | 25.78 | 23.18 | 23.81 | 4.2 | 97 | 2,812 | 50,617 |
| 13 Weeks | 26.50 | 23.14 | 23.51 | 5.5 | 98 | 2,037 | 126,268 |
| 26 Weeks | 26.50 | 21.22 | 21.76 | 14.0 | 94 | 2,133 | 268,756 |
| 52 Weeks | 26.50 | 11.36 | 20.32 | 22.0 | 98 | 2,979 | 744,816 |
| YTD | 26.50 | 11.36 | - | 31.5 | 107 | 2,943 | 671,054 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 24.81 | 24.93 | 24.70 | 23.26 | 21.09 | 1.18 | 1.09 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 6.90 | 73.8 | 7.08 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -16.42 | NA | 7.53 |
| R&D | 5.32 | NA | 5.27 |
| Normalized Inc. | 0.00 | NA | 21.30 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -5.5 | -0.7 | 1.1 |
| Earnings % | -5.3 | 53.5 | -58.3 |
| EPS % | -2.3 | 45.5 | -55.1 |
| EPS $ | -0.01 | 0.05 | -0.75 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 42.77 |
| Current Ratio | 3.3 |
| Quick Ratio (Acid Test) | 2.1 |
| Liquidity Ratio (Cash) | 1.26 |
| Receivables Turnover | 4.0 |
| Average Collection Period | 90 |
| Working Capital/Equity | 68.6 |
| Working Capital pS | 9.54 |
| Cash-Flow pS | 1.20 |
| Free Cash-Flow pS | 1.10 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.21 |
| Financial Leverage Ratio (Assets/Equity) | 1.6 |
| Debt Ratio | 37.6 |
| Total Debt/Equity (Gearing Ratio) | 0.22 |
| LT Debt/Equity | 0.22 |
| LT Debt/Capital Invested | 25.5 |
| LT Debt/Total Liabilities | 36.7 |
| Interest Cover | 5.2 |
| Interest/Capital Invested | 1.16 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.40 |
| Tobin's Q Ratio | 1.12 |
| Current P/E Ratio - LTM | 41.30 |
| Enterprise Value (EV)/EBITDA | 18.89 |
| Enterprise Value (EV)/Free Cash Flow | 32.72 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.80 |
| Price/Book Ratio - LTM | 1.66 |
| Price/Cash Flow Ratio | 21.6 |
| Price/Free Cash Flow Ratio - LTM | 20.9 |
| Price/Sales Ratio | 1.63 |
| P/E Ratio (1 month ago) - LTM | 40.4 |
| P/E Ratio (26 weeks ago) - LTM | 38.2 |
| P/E Ratio (52 weeks ago) - LTM | 25.7 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 31.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 36.0 |
| PER SHARE FIGURES |
| LT Debt pS | 3.08 |
| Current Liabilities pS | 4.06 |
| Tangible Book Value pS - LTM | 13.78 |
| Book Value pS - LTM | 14.97 |
| Capital Invested pS | 16.83 |
| Cash pS - LTM | 3.91 |
| Cash Flow pS - LTM | 1.15 |
| Free Cash Flow pS - LTM | 1.18 |
| Earnings pS (EPS) | 0.61 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 6.85 |
| Free Cash Flow Margin 5YEAR AVG | 3.58 |
| Net Profit Margin | 4.1 |
| Net Profit Margin - 5YEAR AVRG. | 1.6 |
| Equity Productivity | 1.15 |
| Return on Equity (ROE) | 4.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 2.0 |
| Capital Invested Productivity | 0.94 |
| Return on Capital Invested (ROCI) | 3.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 1.3 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | 2.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.0 |
| Gross Profit Margin | 43.4 |
| Gross Profit Margin - 5YEAR AVRG. | 43.3 |
| EBITDA Margin - LTM | 9.9 |
| EBIT Margin - LTM | 6.3 |
| Pre-Tax Profit Margin | 5.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 3.7 |
| Effective Tax Rate | 26.2 |
| Effective Tax Rate - 5YEAR AVRG. | 13.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 230 |
| Revenue per Employee | 332,323 |
| Net Income per Employee | 13,479 |
| Average Collection Period | 84 |
| Receivables Turnover | 4.0 |
| Day's Inventory Turnover Ratio | 146 |
| Inventory Turnover | 2.5 |
| Inventory/Sales | 23.6 |
| Accounts Payble/Sales | 5.84 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 1.68 |
| Fixed Assets Turnover | 1.85 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 4.09 |
| Revenue per $ Plant | 7.78 |
| Revenue per $ Common Equity | 1.15 |
| Revenue per $ Capital Invested | 0.94 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 21.3 |
| Research & Devlopment (R&D) as % of Revenue | 11.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 11.7 |
|
|  
|
| |
 |  |